Alporo, Feleciano M.

HRN: 25-17-20  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/30/2024
06/06/2024
IV
4.5g
Q6
CMBO
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: